Literature DB >> 1091866

Nasal infection of Alcaligenes bronchisepticus (Bordetella bronchiseptica) and lesions in newborn rabbits.

M Maeda, T Shimizu.   

Abstract

The mode of experimental infection with Alcaligenes bronchisepticus (Bordetella bronchiseptica) of pig and rabbit origin, and lesions in the respiratory organs were examined in three groups, A, B and C, of newborn rabbits. Groups A and C were free from the organism and agglutinating antibody and inoculated with the organisms of pig and rabbit origin, respectively. Group B had maternal antibody and was inoculated with the organism of pig origin. Establishment and persistence of infection with the organism were certified in the nasal cavities, trachea, or lungs of groups A and C 3 days after inoculation or later. Late establishment of infection occurred in trachea and lungs of group B. Agglutinating antibody was detected in groups A and B mostly 14 days after inoculation or later. Ventral turbinate atrophy occurred in groups A and B mostly 10 days after inoculation or later. Histologically, it was hypo-osteogenesis caused by degeneration of osteoblasts and proliferation of fibroblast-like cells in the osseous tissue. Catarrhal inflammation in the nasal and tracheal mucous membranes, and bronchopneumonia with peribronchiolitis developed commonly in all the groups. The fluorescent antibody technique revealed antigen of the organism of pig origin on the nasal mucosa, mostly of the dorsal and ventral meatus, and on the tracheal and bronchiolar mucosa in groups A and B.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091866

Source DB:  PubMed          Journal:  Natl Inst Anim Health Q (Tokyo)        ISSN: 0027-951X


  7 in total

1.  Adherence of Pasteurella multocida or Bordetella bronchiseptica to the swine nasal epithelial cell in vitro.

Authors:  T Nakai; K Kume; H Yoshikawa; T Oyamada; T Yoshikawa
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

2.  Isolation and characterization of mutant strains of Bordetella bronchiseptica lacking dermonecrotic toxin-producing ability.

Authors:  H Nagano; T Nakai; Y Horiguchi; K Kume
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

3.  Purification of dermonecrotic toxin from a sonic extract of Pasteurella multocida SP-72 serotype D.

Authors:  T Nakai; A Sawata; M Tsuji; Y Samejima; K Kume
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

Review 4.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

Review 5.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

6.  Prophylaxis of Bordetella bronchiseptica infection in guinea pigs by intranasal vaccination with live strain ts-S34.

Authors:  T Shimizu
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

7.  Properties of dermonecrotic toxin prepared from sonic extracts Bordetella bronchiseptica.

Authors:  K Kume; T Nakai; Y Samejima; C Sugimoto
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.